What Does a Privia Health Insider’s Sale of Company Shares for $3.6 Million Mean for Investors?
Shawn Morris, former CEO and previously a member of the Board of Directors at Privia Health Group (PRVA 1.01%), reported the exercise of 135,498 stock options into common shares and immediately sold them for proceeds of approximately ~$3.57 million, as disclosed in the SEC Form 4 filing.
Transaction summary
| Metric | Value |
|---|---|
| Shares sold (direct) | 135,498 |
| Transaction value | ~$3.6 million |
| Post-transaction shares (direct) | 76,651 |
| Post-transaction shares (indirect) | 24,485 |
| Post-transaction value (direct ownership) | ~$2.1 million |
Transaction value based on SEC Form 4 weighted average reported price ($26.32); post-transaction value based on July 1, 2026 market close.
Key questions
- What was the structure and rationale of this transaction?
This was an exercise-and-immediate-sale event, where 135,498 options were converted into common shares and then disposed of, providing liquidity while leaving Morris’ substantial options position intact. - How did the sale impact Morris’ equity exposure in Privia Health Group?
The direct common share position was reduced by 63.87%. - Did the transaction reflect a change in trading cadence or capacity?
The scale of this sale was materially larger than prior historic sales, but this increase is capacity-driven, as Morris’ available share pool has contracted after multiple prior disposals since December of last year. - What is the current context for Privia Health Group shares as of July 1, 2026?
The stock closed at $26.88 on July 1, 2026, up 19.3% over the trailing year, and the transaction occurred at a slight discount to this level.
Company overview
| Metric | Value |
|---|---|
| Revenue (TTM) | $2.25 billion |
| Net income (TTM) | $21.76 million |
| Employees | 1,140 |
| 1-year price change | 19.30% |
* 1-year performance calculated using July 1, 2026 as the reference date.
Company snapshot
- Privia Health offers technology-enabled management services, population health tools, and a national provider network, generating revenue primarily through management fees and value-based care contracts.
- It operates a platform-based business model, supporting independent physician groups with practice management, payer contracting, and clinical integration to drive cost efficiency and quality outcomes.
- The company serves independent physicians, medical groups, health plans, and health systems across the United States, targeting providers seeking to optimize clinical and financial performance.
Privia Health Group, Inc. is a national healthcare services company specializing in physician enablement and value-based care delivery. The company leverages a scalable technology platform and management services organization to streamline provider operations and enhance care coordination.
Its integrated approach to practice management and population health positions Privia as a strategic partner for clinicians navigating the shift toward value-based reimbursement. The company’s scale and network breadth provide a competitive edge in payer negotiations and clinical integration.
What this transaction means for investors
Former CEO Shawn Morris’ sale of Privia stock on June 30 and July 1 occurred just days before he retired from the Board of Directors on July 6. The transactions at a weighted average price of $26.32 came at a time when shares were rising, eventually hitting a 52-week high of $27.86 on July 10.
Morris’ conversion of stock options into common shares and selling them immediately is a tactic often implemented by executives, so his disposition is not unusual. Moreover, these were non-discretionary transactions as part of a pre-arranged Rule 10b5-1 trading plan. Such plans allow insiders to sell shares at predetermined times to avoid concerns of trading on non-public information.
As of July 1, Morris retained a sizable equity stake in Privia Health Group. Along with 76,651 directly-held shares in the company, he possessed millions of fully-vested stock options and over 24,000 shares held indirectly through a trust and LLC. Consequently, Morris’ disposition may have reduced his direct holdings by nearly 64%, but he has plenty of stock options remaining.
Privia Health shares rose thanks to excellent first-quarter sales growth of nearly 26% year over year to $603.8 million. The company also announced it was expanding into the state of New Jersey, which should boost sales further.
